PReS-FINAL-2168: Comparison of safety and retention rate of TNF antagonist therapy in juvenile-onset and adult-onset ankylosing spondylitis: data from the spanish registry biobadaser 2.0

Podobne knjige/članki

• PReS-FINAL-2032: Changes in immunogenic profile in patients with juvenile idiopathic arthritis exposed to anti tumoral necrosis factor therapy
  od: Guillen Astete, CA, et al.
  Izdano: (2013)
• PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
  od: Guillen Astete, CA, et al.
  Izdano: (2013)
• PReS-FINAL-2185: Prognostic markers in juvenile vs. adult-onset ankylosing spondylitis
  od: Jadon, D, et al.
  Izdano: (2013)
• PReS-FINAL-2115: Differences in musculoskeletal clinical expression between Spanish and Mexican patients with juvenile spondyloarthritis: data from the Mexespa project
  od: Sifuentes Giraldo, WA, et al.
  Izdano: (2013)
• Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER
  od: Carmona, Loreto, et al.
  Izdano: (2006)